One-Time DNA Study for Vasculitis
NCT01241305 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2026-01-22
Summary
The purpose of this study is to identify genes that increase the risk of developing vasculitis, a group of severe diseases that feature inflammation of blood vessels. Results of these studies will provide vasculitis researchers with insight into the causes of these diseases and generate new ideas for diagnostic tests and therapies, and will be of great interest to the larger communities of researchers investigating vasculitis and other autoimmune, inflammatory, and vascular diseases.
Conditions
- Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)
- Giant Cell Arteritis
- Granulomatosis With Polyangiitis (Wegener's)
- Microscopic Polyangiitis
- Polyarteritis Nodosa
- Takayasu's Arteritis
Sponsors & Collaborators
-
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
collaborator NIH -
Office of Rare Diseases (ORD)
collaborator NIH -
Rare Diseases Clinical Research Network
collaborator NETWORK - lead OTHER
Principal Investigators
-
Peter Merkel, MD, MPH · University of Pennsylvania
Eligibility
- Min Age
- 7 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-10-31
- Primary Completion
- 2028-08-31
- Completion
- 2028-08-31
Countries
- United States
- Canada
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Determining Disease Activity Biomarkers in Individuals With Giant Cell Arteritis
NCT00315497 ·Status: COMPLETED
-
Analysis of Bronchial Tissue and Fluid in Patients With Wegener's Granulomatosis
NCT00001541 ·Status: COMPLETED
-
Vasculitis Pregnancy Registry
NCT02593565 ·Status: RECRUITING
-
Autoimmune and Autoinflammatory Genetics Study
NCT06004349 ·Status: RECRUITING
-
Reproductive Health in Men and Women With Vasculitis
NCT02176070 ·Status: COMPLETED
-
Aetiology of TemporaL Arteritis Study
NCT02584517 ·Status: WITHDRAWN
-
Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis
NCT00315380 ·Status: RECRUITING
-
Intravenous Immunoglobulin After Relapse in Vasculitis
NCT00307658 ·Status: TERMINATED ·Phase: PHASE3
-
Hematopoietic Stem Cell Support in Vasculitis
NCT00278512 ·Status: TERMINATED ·Phase: PHASE1
-
Study of Refractory and/or Relapsing TAkayasu aRTeritis
NCT03543527 ·Status: UNKNOWN
-
The ANCA Vasculitis Questionnaire (AAV-PRO©)
NCT02507024 ·Status: COMPLETED
-
Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositis
NCT00059748 ·Status: RECRUITING
-
Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis
NCT00104299 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Impact of Vasculitis on Employment and Income
NCT02476292 ·Status: COMPLETED
-
Alemtuzumab for ANCA Associated Refractory Vasculitis
NCT01405807 ·Status: UNKNOWN ·Phase: PHASE4
-
Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis
NCT00468208 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Biocollection of Patients With ANCA Associated Vasculitis
NCT05364892 ·Status: RECRUITING ·Phase: NA
-
Immunity Against AAV in Crigler Najjar Patient
NCT02302690 ·Status: COMPLETED
-
Tailoring Maintenance Therapy to Cluster of Differentiation 5 Positive (CD5+) Regulatory B Cell Recovery in ANCA Vasculitis
NCT03906227 ·Status: TERMINATED ·Phase: NA
-
Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years
NCT00307671 ·Status: COMPLETED ·Phase: PHASE4
-
Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis
NCT02169219 ·Status: COMPLETED ·Phase: PHASE4
-
Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides
NCT00001473 ·Status: COMPLETED
-
Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis)
NCT01862068 ·Status: COMPLETED
-
PRO Development for ANCA Associated Vasculitis
NCT01729624 ·Status: UNKNOWN
-
Rituximab Plus Corticosteroids in Non-infectious Active Mixed Cryoglobulinemia Vasculitis
NCT02556866 ·Status: TERMINATED ·Phase: PHASE2